IP Verse

Biosynthetic Heparin

Patent No. EP3510147 (titled "Biosynthetic Heparin") was filed by Rensselaer Polytechnic Institute on Sep 7, 2017. The application was issued on May 17, 2023.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
SANOFIFeb 16, 2024CABINET NONY
SANOFIFeb 16, 2024IPSILON

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3510147

RENSSELAER POLYTECHNIC INSTITUTE
Application Number
EP17849497A
Filing Date
Sep 7, 2017
Status
Granted And Under Opposition
Apr 14, 2023
Publication Date
May 17, 2023
External Links
Slate, Register , Google Patents